Isolation and characterization of cancer chemopreventive compounds from Barringtonia maunwongyathiae

Pharmaceutical Biology

Volumn 45, Issue 3, 2007, Pages 185-194

  Jutiviboonsuk, Aranya ^a   Zhang, Hong Jie ^b   Kondratyuk, Tamara P ^c   Herunsalee, Angkana ^d   Chaukul, Wongsatit ^a   Pezzuto, John M ^c   Fong, Harry H S ^a   Bunyapraphatsara, Nuntavan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c PURDUE UNIVERSITY   (United States)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Antioxidant responsive element (ARE); ARE luciferase reporter system; Barringtonia maunwongyathiae; Cancer chemoprevention; Coumaroyl triterpenes; COX 1; COX 2; Lecythidaceae; NF B luciferase reporter system; Ornithine decarboxylase (ODC)g48

Indexed keywords

3 COUMAROYL ALPHA AMYRIN; 3 COUMAROYL BETA AMYRIN; 3 COUMAROYLLUPEOL; 3 COUMAROYLTARAXEROL; 3,19,24 TRIHYDROXYURS 12 EN 28 OIC ACID; 30 BETA DEXTRO GLUCOPYRANOSYLSTIGMASTA 5,22 DIENE; ALPHA TOCOPHERYLQUINONE; ANTINEOPLASTIC AGENT; BARRINGTONIA MAUNWONGYATHIAE EXTRACT; BETA STIGMASTEROL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; ORNITHINE DECARBOXYLASE; PLANT EXTRACT; STIGMA 4,22 DIEN 3 ONE; TARAXEROL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BARRINGTONIA MAUNWONGYATHIAE; CANCER PREVENTION; CIS TRANS ISOMERISM; CONTROLLED STUDY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEDICINAL PLANT; PROTEIN EXPRESSION;

BARRINGTONIA; LECYTHIDACEAE;

EID: 34247584005     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701213062     Document Type: Article

References (56)

1. Aggarwal BB (2004): Nuclear factor-κB. The enemy within. Cancer Cell 6: 203-208.
2. Alam MS, Chopra N, Ali M, Niwa M (1996): Oleanen and stigmasterol derivatives from Ambroma augusta. Phytochemistry 41: 1197-1200.
3. Almeida MLS, Kočovský P, Bäckvall JE (1996): Ruthenium-catalyzed Oppenauer-type oxidation of 3β-hydroxy steroids. A highly efficient entry into the steroidal hormones with 4-en-3-one functionality. J Org Chem 61: 6587-6590.
4. Anjaneyulu ASR, Sastry CSP, Narayan GKASS, Row LR (1978): New triterpenes from Barringtonia acutangula Gaertn. J Indian Chem Soc 55: 1169-1174.
5. Bachrach U, Wang YC (2002): Cancer therapy and prevention by green tea: Role of ornithine decarboxylase. Amino Acids 22: 1-13.
6. Baldwin AS (2001): Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246.
7. Barua AK, Maiti PC, Chakraborti SK (1961): Triterpenoids XI. New triterpenoid sapogenins from the fruits of Barringtonia acutangula. J Pharm Sci 50: 937-940.
8. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, Zick A, Sharoni Y, Lavy J (2005): Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4: 177-186.
9. Bharti AC, Aggarwal BB (2002): Nuclear factor-kappa B and cancer: Its role in prevention and therapy. Biochem Pharmacol 64: 883-888.
10. Burton RA, Wood SG, Owen NL (2003): Elucidation of a new oleanane glycoside from Barringtonia asiatica. Arkivoc 13: 137-146.
11. Chang CI, Kuo YH (1998): Three new lupane-type triterpenes from Diospyros maritima. Chem Pharm Bull 46: 1627-1629.
12. Chantaranothai P (1995): Barringtonia (Lecythidaceae) in Thailand. Kew Bull 50: 677-705.
13. Chuakul W (2001): Barringtonia maunwongyathiae (Lecythidaceae): A new species from Thailand. Blumea 46: 575-579.
14. Chun KS, Surh YJ (2004): Signal transduction pathways regulating cyclooxygenase-2 expression: Potential molecular targets for chemoprevention. Biol Pharmacol 68: 1089-1100.
15. Cuendet M, Pezzuto JM (2000): The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metab Drug Interac 17: 109-157.
16. Deraniyagala SA, Ratnasooriya WD, Goonasekara CL (2003): Antinociceptive effect and toxicological study of the aqueous bark extract of Barringtonia racemosa on rats. J Ethnopharmacol 86: 21-26.
17. Dorai T, Aggarwal BB (2004): Role of chemopreventive agents in cancer therapy. Cancer Lett 215: 129-140.
18. Earashi M, Noguchi M, Kinoshita K, Tanaka M (1995): Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of human breast cancer cell line. Oncology 52: 150-155.
19. Feith DJ, Bol DK, Carboni JM, Lynch MJ, Sass-Kuhn S, Shoop PL, Shantz LM (2005): Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase-induced skin tumorigenesis. Cancer Res 65: 572-578.
20. Gerhäuser C, Mar W, Lee SK, Suh N, Luo Y, Kosmeder J, Luyengi L, Fong HH, Kinghorn AD, Moriarty RM, et al. (1995): Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat Med 1: 260-266.
21. Gerhäuser C, You M, Liu J, Moriarty RM, Hawthorne M, Mehta RG, Moon RC, Pezzuto JM (1997): Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 57: 272-278.
22. Hasan CM, Khan S, Jabbar A, Rashid MA (2000): Nasimaluns A and B: neo-Clerodane diterpenoids from Barringtonia racemosa. J Nat Prod 63: 410-411.
23. Herlt AJ, Mander LN, Pongoh E, Rumampuk RJ, Tarigan P (2002): Two major saponins from seeds of Barringtonia asiatica: Putative antifeedants toward Epilachna sp. larvae. J Nat Prod 65: 115-120.
24. Homhual S, Zhang HJ, Bunyapraphatsara N, Kondratyuk TP, Santasiero BD, Mesecar AD, Herunsalee A, Chaukul W, Pezzuto JM, Fong HHS (2005a): Bruguiesulfurol, a new sulfur compound from Bruguiera gymnorrhiza. Planta Med (in press).
25. Homhual S, Bunyapraphatsara N, Kondratyuk TP, Herunsalee A, Chaukul W, Pezzuto JM, Fong HHS, Zhang HJ (2005b): Bioactive dammarane triterpenes from the mangrove plant Bruguiera gymnorrhiza. J Nat Prod (submitted).
26. Hsieh JT, Verma AK (1988): Involvement of protein kinase C in the transcriptional regulation of ornithine decarboxylase gene expression by 12-O-tetradecanoylphorbol-13-acetate in T24 human bladder carcinoma cells. Arch Biochem Biophys 262: 326-336.
27. Infante JP (1999): A function for the vitamin E metabolite α-tocopherol quinone as an essential enzyme cofactor for the mitochondrial fatty acid desaturases. FEBS Lett 446: 1-5.
28. Jang DS, Cuendet M, Hawthorne ME, Kardono LB, Kawanishi K, Fong HH, Mehta RG, Pezzuto JM, Kinghorn AD (2002): Prenylated flavonoids of the leaves of Macaranga conifera with inhibitory activity against cyclooxygenase-2. Phytochemistry 61: 867-872.
29. Khan MR, Omoloso AD (2002): Antibacterial and antifungal activities of Barringtonia asiatica. Fitoterapia 73: 255-260.
30. Khan S, Jabbar A, Hasan CM, Rashid MA (2001): Antibacterial activity of Barringtonia racemosa. Fitoterapia 72: 162-164.
31. Kong A-NT, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R, Mandlekar S (1980): Signal transduction events elicited by cancer prevention compounds. Mutat Res 480-481: 231-241.
32. Laphookhieo S, Karalai C, Ponglimanont C, Chantrapromma K (2004): Pentacyclic triterpenoid esters from the fruits of Bruguiera cylindrical. J Nat Prod 67: 886-888.
33. Li Q, Withoff S, Verma M (2005): Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26: 318-325.
34. McCann P, Pegg AE (1992): Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther 54: 195-215.
35. McClatchey W (1996): The ethnopharmacopoeia of Rotuma. J Ethnopharmacol 50: 147-156.
36. 1H shift correlation spectra. Magn Reson Chem 32: 422-428.
37. Nakanishi C, Toi M (2005): Nuclear factor κB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5: 297-309.
38. Nakatani M, Miyazaki Y, Iwashita T, Naoki H, Hase T (1989): Triterpenes from Ilex rotunda fruits. Phytochemistry 28: 1479-1482.
39. Öksüz S, Ulubelen A, Barla A, Kohlbau HJ, Voelter W (1999): Triterpenoids and a diterpene from Euphorbia iberica. Planta Med 65: 475-477.
40. Olson GL, Cheung HC, Morgan K, Saucy G (1980): A new synthesis of α-tocopherol. J Org Chem 45: 803-805.
41. Pal BC, Chaudhuri T, Yoshikawa K, Arihara S (1994): Saponins from Barringtonia acutangula. Phytochemistry 35: 1315-1318.
42. Panthong A, Kanjanapothi D, Taylor WC (1986): Ethnobotanical review of medicinal plants from Thai traditional books, part I: Plants with anti-inflammatory, anti-asthmatic and antihypertensive properties. J Ethnopharmacol 18: 213-228.
43. Payens JPDW (1967): A monograph of the genus Barringtonia (Lecythidaceae). Blumea 15(2): 157-263.
44. Pezzuto J, Kosmeder II J, Park E, Lee S, Cuendet M, Gills J, Bhat K, Grubjesic S, Park H, Mata-Greenwood E, Tan Y, Yu R, Lantvit D, Kinghorn A (2005): In: Kelloff GJ, Hawk ET, Sigman CC, eds., Cancer Chemoprevention Strategies for Cancer Chemoprevention, Vol. 2. Totowa, NJ, Humana Press, pp. 3-37.
45. Ramirez-Mares MV, Chandra S, Mejia EG (2004): In vitro chemopreventive activity of Camellia sinensis, Ilex paraguariensis and Ardisia compressa tea extracts and selected polyphenols. Mutat Res 554: 53-65.
46. Rao GSRS, Prasanna S, Kumar VPS, Yadagiri B (1986): New triterpenes from Barringtonia speciosa Forst. Indian J Chem 25B: 113-122.
47. Sastry CSP, Row LR (1967): New triterpenes from Barringtonia acutangula Gaertn-III. The constitution of Tanginol, a new hexahydroxy triterpene. Tetrahedron 23: 3837-3846.
48. Shukla S, Gupta S (2004): Suppression of constitutive and tumor necrosis factor α-indiced nuclear factor (NF)-κB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: Correlation with down-regulation of NF-κB-responsive genes. Clinical Cancer Res 10: 3169-3178.
49. Stocker A, Baumann U (2003): Supernatant protein factor in complex with RRR-α-tocopherylquinone: A link between oxidized vitamin E and cholesterol biosynthesis. J Mol Biol 332: 759-765.
50. Surh YJ, Chun KS, Cha HH (2001): Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 480-481: 243-268.
51. Takahashi H, Iuchi M, Fujita Y, Minami H, Fukuyama Y (1999): Coumaroyl triterpenes from Casuarina equisetifolia. Phytochemistry 51: 543-550.
52. Talalay P, Dinkova-Kostova AT, Holtzclaw WD (2003): Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 43: 121-134.
53. Thomas TJ, Panikkar B, Subramoniam A, Nair MK, Panikkar KR (2002): Antitumour property and toxicity of Barringtonia racemosa Roxb seed extract in mice. J Ethnopharmacol 82: 223-227.
54. Waffo-Teguo P, Hawthorne ME, Cuendet M, Mérillon J-M, Kinghorn AD, Pezzuto JM, Mehta RG (2001): Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer 40: 173-179.
55. Wang D, Dubois RN (2006): Prostaglandins and cancer. Gut 55: 115-122.
56. Zhang Y, Talalay P, Cho CG, Posner GS (1992): A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc Natl Acad Sci USA 89: 2399-2403.